GSK's Omjjara (momelotinib) approved in Singapore as the first treatment indicated for myelofibrosis patients with anaemia
GSK Singapore today announced that Omjjara (momelotinib) has been locally approved for treatment of disease-related ...
British investor eyes 23andMe rescue as it files for bankrupcy
A major British investor is exploring a potential rescue plan for 23andMe, after the company filed for bankrupcy protection ...
manilatimes20d
Report: RSV-associated Hospitalisation Costs in Singapore Estimated at SGD 9,430 per Patient; Poses Financial Strain on At-risk Older Adults
8-10 Dr Lee Tau Hong, Infectious Disease Specialist, Infectious Diseases Care Clinic in Singapore, shared with GSK, "RSV poses a significant burden on patients, families, and healthcare systems ...
AFAQS26d
Coca-Cola's Carson Dalton joins GSK as EVP- Communications & Govt Affairs
Carson Dalton has joined GSK as executive vice president of communications ... leading communications for the Asia Pacific region from Singapore. Earlier, he established the PR function at Idea ...
pharmaphorum4d
FDA set to decide on GSK's gepotidacin antibiotic in March
according to GSK. At the same time, antimicrobial resistance (AMR) to common drugs used to treat these infections is on the rise, leading to treatment failure, with a Singapore study published ...
Le Lézard18d
ViiV Healthcare's investigational broadly neutralising antibody - N6LS - successfully maintains viral suppression in long-acting treatment of HIV
About GSK GSK is a global biopharma company with a purpose to unite ... at 19:52 MonstarX AI Workflow Disrupts Singapore's Tech Scene: Building Enterprise Software 6x Faster, 5x Cheaper Monstarlab is ...
American Association of Individual Investors4d
Why Wave Life Sciences Ltd.’s (WVE) Stock Is Down 10.08%
Wave Life Sciences Ltd.’s WVE share price has dipped by 10.08%, which has investors questioning if this is right time to buy.
pharmaphorum8d
AbbVie invests $223m in Singapore biologics site
GSK, Pfizer, Sanofi, MSD, Novartis, and Roche among AbbVie’s neighbours. “We are grateful for AbbVie’s continued trust in the strength of Singapore’s biopharmaceutical manufacturing ...